Forma Therapeutics joins the Life Sciences portfolio in 2021. The project arrives at the moment the sector is at full height, accelerated by pandemic-era demand. The firm’s architectural answer is a building that can house both quiet, computational science and the fast-moving collaboration the industry now requires.